Sienna Biopharmaceuticals appoints CFO
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Sustainability Outlook
The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism
California-based Sienna Biopharmaceuticals Inc. appointed John Smither as CFO.
Smither served as the company's CFO from January 2016 to March 2017, and subsequently served as an independent consultant in the biopharmaceutical industry.
Smither will succeed Richard Peterson, who resigned for personal reasons, effective March 29.
